Icoreconnect Inc. (VMCI) SEC Filing 8-K Material Event for the period ending Monday, October 23, 2017


CIK: 746598 Ticker: VMCI

View differences made from one to another to evaluate Imedicor's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Imedicor.


Assess how Imedicor's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Imedicor's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: VMCI
CIK: 1408057
Form Type: 8-K Corporate News
Accession Number: 0001654954-17-009678
Submitted to the SEC: Wed Oct 25 2017 3:44:45 PM EST
Accepted by the SEC: Wed Oct 25 2017
Period: Monday, October 23, 2017
Industry: Prepackaged Software
  1. Accountant Change

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: